Infectious Aortitis and Mycotic Abdominal Aneurysm Secondary to Cat Bite Injury
July 24th 2016A recent report describes a case of infectious aortitis and resultant mycotic abdominal aneurysm that arose as rare complications of exposure to Pasteurella multocida from a cat bite in a male patient.
Read More
Study Reveals How Green Tea Could Protect Against Zika Virus
July 12th 2016A molecule in green tea, known as epigallocatechin (EGCG), blocks the entry of a Brazilian strain of Zika virus into host cells, and may hold potential benefit for prevention of Zika virus infections, a new study has found.
Read More
CDC Issues Warning About Multidrug-Resistant Candida Species
July 7th 2016In a recent clinical alert, the Centers for Disease Control and Prevention (CDC) warned US healthcare facilities about Candida auris, an emerging multidrug-resistant (MDR) yeast that is causing severe, and sometimes fatal, healthcare-associated infections.
Read More
A Single Strain of Plague Caused Recurrent Outbreaks Over Many Centuries: Yersinia pestis
June 17th 2016A new study has suggested that Yersinia pestis—the causative agent of plague—likely entered Europe only once, and later spread to China where it has become the source of modern plague outbreaks.
Read More
Emerging Trends in Tick-borne Diseases in the United States
June 15th 2016In a webinar presented on June 9 by The Department of Health and Human Services (HHS) Working Group on Lyme and Other Tick-borne Diseases, a panel of speakers discussed trends in tick-borne diseases (TBDs) in the United States.
Read More
HCV Cure Rates in HIV Patients, Lower in Real-World than in Clinical Trials
June 14th 2016Hepatitis C virus (HCV) cure when using direct-acting antiviral (DAA) agents in human immunodeficiency virus (HIV)-coinfected patients is lower in real-world settings than when patients are enrolled in clinical trials, a new study has found.
Read More
Studies Highlight Worldwide Economic Burden of Norovirus Gastroenteritis
June 6th 2016Each year, norovirus infection is responsible for an estimated 684 million episodes of diarrhea and 212,000 deaths worldwide, and results in approximately $4.2 billion in healthcare costs and $60.3 billion in societal costs, a new report has highlighted.
Read More
Ledipasvir-Sofosbuvir for 8 Weeks: Effective and Cost-effective Against HCV
June 1st 2016A recent study in treatment-naïve patients with chronic hepatitis C virus (HCV) infection has shown that ledipasvir/sofosbuvir (LDV/SOF) combination therapy produces similar sustained virologic response (SVR) rates in clinical trial-based studies and real-world studies.
Read More
CDC Releases Updated Guidelines on HIV Nonoccupational Post-Exposure Prophylaxis
May 27th 2016The Centers for Disease Control and Prevention (CDC) has released updated guidelines for the use of nonoccupational post-exposure prophylaxis (nPEP) in persons in the United States, after exposure to human immunodeficiency virus (HIV) outside the health care setting.
Read More
HPV-Related Health Problems Linked With Stress and Depression
May 16th 2016A recent study has shown that stress and depression in adolescent females are linked to human papillomavirus (HPV)-related health problems—in particular, whether the viral infection persists long enough to increase the risk of cervical cancer.
Read More
Study Shows HIV Can Develop Resistance to Promising HIV Therapy
April 28th 2016A recent study has shown that although the CRISPR/Cas9 gene editing technology can stop human immunodeficiency virus (HIV) replication, it also results in unexpected viral resistance and thereby limits use of the technology in HIV therapy.
Read More
Study Challenges WHO Recommendation to Increase HCV Screening in HIV-Infected Populations
April 27th 2016In a recent study of 1,812 human immunodeficiency virus (HIV)-infected individuals in sub-Saharan Africa, researchers found that none of these individuals had confirmed hepatitis C virus replication.
Read More
Parasitic Diseases of the Central Nervous System: Treatment and Control
April 13th 2016This article is the third in a 3-part series on parasitic diseases of the central nervous system (CNS) and it highlights some of the treatment advances that are available for patients with these diseases, as well as disease control strategies that have been implemented by the World Health Organization (WHO) and other partners.
Read More